A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerR. Charles Coombes, Judith M. Bliss, Emma Hall et al.|New England Journal of Medicine|2004Cited by 1.8k
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trialR. Charles Coombes, Judith M. Bliss, Lucy Kilburn et al.|The Lancet|2007Cited by 912
Supplementary Material for: Magnetic Resonance Biomarkers and Neurological Outcome of Infants with Mild Hypoxic-Ischaemic Encephalopathy Who Progress to Moderate Hypoxic-Ischaemic EncephalopathyPaolo Montaldo, Mario Cirillo, S Ascione et al.|Figshare|2022Cited by 0